NL-OMON33816撤回不适用
Immunisation of pregnant women with acellular Bordetella pertussis vaccine. - Bordetella pertussis vaccination in pregnancy
适应症
试验速览
- 阶段
- 不适用
- 状态
- 撤回
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Zie protocol pagina 16
排除标准
- •Zie protocol pagina 16
研究者
相似试验
招募中
Unknown
Pregnancy Immunobiology StudyNeuromyelitis Optica Spectrum DisorderNeurological - Multiple sclerosisNeurological - Other neurological disordersMultiple SclerosisACTRN12623000951651Monash University249
已完成
不适用
Study of Rubella Immunity. Response to Vaccination of Subjects With Very Low, Equivocal or Undetectable Titers of Rubella Virus AntibodiesPregnancyNCT02934295Hopital Foch192
已完成
不适用
Bordetella pertussis serology in pregnancyB. pertussis infection in pregnancyPregnancy and ChildbirthInfection in pregnancyISRCTN14204141Groene Hart Hospital (The Netherlands)500
进行中（未招募）
1 期
TDaP (Tetanus, Diphtheria, acellular Pertussis) immunization during pregnancy results in an augmentation of maternal antibodies, which are in turn transferred from the mother to fetus and offer additional protection to the newborn infant during the first months of life. The role of these high maternal antibodies levels on the infant’s immune responses after vaccination will be assessed in term and preterm infants (the MAMA study).EUCTR2020-003466-39-BEniversity of Antwerp300
进行中（未招募）
1 期
Babies born early Antibody Response to Men B VaccinatioEUCTR2017-001487-38-GBSt George's, University of London132